Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

National Arts Council opens doors for students in Drama and Theatre Arts
2017-06-29

Description: National Arts Council opens doors for students  Tags: National Arts Council opens doors for students

Four postgraduate students from the University of the
Free State received bursaries from the National Arts
Council this year. They are, from the left: Gerrit Fourie,
Maryn Hattingh, Prof Pieter Venter, Programme Director
of drama at the UFS, Stella Nortier, and Franco de Wet. 
Photo: Esté Strydom

Thanks to bursaries from the National Arts Council (NAC), many students are finding it easier to study Drama and Theatre Arts, the discipline is able to offer more job opportunities, and it provides an opportunity to those who probably would never have had the chance. This is according to Prof Nico Luwes, Head of the Department of Drama and Theatre Arts at the University of the Free State (UFS).

This year, several students from the UFS, including 12 undergraduates and four postgraduates, are again beneficiaries of NAC bursaries to the value of roughly R206 000 – about R150 000 of which will be used for undergraduate studies and R56 000 for postgraduate studies. The UFS was awarded the same amount for undergraduate students in the previous year, but didn’t then receive NAC bursaries for postgraduate studies.

Good relationship with NAC over many years
The UFS has received NAC bursaries since 2005, and Prof Luwes says the university’s good relationship with the council runs over many years. “They are very happy with the feedback on our students’ achievements,” he says.

“Although Dramatic Arts is a matric subject, the provincial department of education does not support students with education bursaries for this subject. With bursaries from the National Arts Council, students can thus study to become theatre artists, and work as teachers for the Dramatic Arts in schools.”

Alumni stand out in entertainment industry
Prof Luwes says his department provides students the opportunity to do performances and practical exams in English, Afrikaans, and Sesotho. This is done to give all students an equal opportunity to excel. “In addition, several of our alumni have achieved success in the entertainment industry, and our staff members often feature in professional performances at arts festivals.”

Undergraduate students who were awarded NAC bursaries:
•    Jolene Swartz
•    Boitumelo Mohutsioa
•    René Lombard
•    Mandisa Wiso
•    Thapelo Mabona
•    Charlize Oberholster
•    Thembisile Baai
•    Naledi Maolusi
•    Mbuyiselo Nqodi
•    Vuyiswa Mxasa
•    Deandi Scholtz
•    Dylan Britz

Postgraduate students who were awarded NAC bursaries:

•    Gerrit Fourie
•    Maryn Hattingh
•    Stella Nortier
•    Franco de Wet

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept